Get started
Work

Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells

Year: 2013
Type: article
Study design: Clinical Trial
Abstract: The use of plerixafor for mobilization following chemotherapy has not been extensively studied. We tested the hypothesis that adding plerixafor to G-CSF after chemotherapy would increase the proportion of patients mobilizing the target number of hematopoietic progenitor cells in one day to 75% from a historical value of 50%.
DOI: 10.1016/j.bbmt.2012.11.195
Authors: Edmund K. Waller, Heather Renfroe Johnson, Neera Jagirdar, Cynthia Gaylor, Carol Lipscomb, Christopher Flowers, Jonathan Kaufman, H. Jean Khoury, Amelia Langston, MaryJo Lechowicz, Sagar Lonial, Ajay Nooka, Rajni Sinha, R. Donald Harvey
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2062015382
FWCI:
Cites:
Cited by:
Related to: 10